nach oben

Erschienen in:

04.04.2019 | Letter to Editor

A Report of Novel STIM1 Deficiency and 6-Year Follow-Up of Two Previous Cases Associated with Mild Immunological Phenotype

verfasst von: Laura Rice, Claire Stockdale, Ian Berry, Sean O’Riordan, Karen Pysden, Rashida Anwar, Roger Rushambuza, Moira Blyth, Sonal Srikanth, Yousang Gwack, Yasser M. El-Sherbiny, Clive Carter, Sinisa Savic

Erschienen in: Journal of Clinical Immunology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Excerpt

To the Editor, …

Nur mit Berechtigung zugänglich

Picard C, McCarl C-A, Papolos A, Khalil S, Lüthy K, Hivroz C, et al. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med. 2009;360(19):1971–80. https://doi.org/10.1056/NEJMoa0900082.CrossRefPubMedPubMedCentral

Feske S, Prakriya M, Rao A, Lewis RS. A severe defect in CRAC Ca²⁺ channel activation and altered K⁺ channel gating in T cells from immunodeficient patients. J Exp Med. 2005;202(5):651–62. https://doi.org/10.1084/jem.20050687.CrossRefPubMedPubMedCentral

Feske S, Picard C, Fischer A. Immunodeficiency due to mutations in ORAI1 and STIM1. Clin Immunol (Orlando, FL). 2010;135(2):169–82. https://doi.org/10.1016/j.clim.2010.01.011.CrossRef

Srikanth S, Woo JS, Wu B, El-Sherbiny YM, Leung J, Chupradit K, Rice L, Seo GJ, Calmettes G, Ramakrishna C, Cantin E, An DS, Sun R, Wu T-T, Jung JU, Savic S, Gwack Y. STIM1 regulates type I interferon response by retaining STING at the endoplasmic reticulum. Nat Immun 2018- accepted for publication.

Furuichi T, Dai J, Cho T, et al. CANT1 mutation is also responsible for Desbuquois dysplasia, type 2 and Kim variant. J Med Genet. 2011;48:32–7. https://doi.org/10.1136/jmg.2010.080226.CrossRefPubMed

Kim OH, Nishimura G, Song HR, Matsui Y, Sakazume S, Yamada M, et al. A variant of Desbuquois dysplasia characterized by advanced carpal bone age, short metacarpals, and elongated phalanges: report of seven cases. Am J Med Genet A. 2010;152A(4):875–85.CrossRefPubMed

Balasubramanian K, Li B, Krakow D, Nevarez L, Ho PJ, Ainsworth JA, et al. MED resulting from recessively inherited mutations in the gene encoding calcium-activated nucleotidase CANT1. Am J Med Genet A. 2017;173(9):2415–21. https://doi.org/10.1002/ajmg.a.38349.CrossRefPubMedPubMedCentral

Nizon M, Huber C, De Leonardis F, Merrina R, Forlino A, et al. Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis. Hum Mutat. 2012;33(8):1261–6.CrossRefPubMedPubMedCentral

Bui C, Huber C, Tuysuz B, Alanay Y. 1 mutations in Desbuquois dysplasia type 2. Am J Hum Genet. 2014;94(3):405–14.CrossRefPubMedPubMedCentral

10.

Parry DA, Holmes TD, Gamper N, el-Sayed W, Hettiarachchi NT, Ahmed M, et al. A homozygous STIM1 mutation impairs store-operated calcium entry and natural killer cell effector function without clinical immunodeficiency. J Allergy Clin Immunol. 2016;137(3):955–957.e8. https://doi.org/10.1016/j.jaci.2015.08.051.CrossRefPubMedPubMedCentral

11.

Byun M, Abhyankar A, Lelarge V, Plancoulaine S, Palanduz A, Telhan L, et al. Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma. J Exp Med. 2010;207(11):2307–12. https://doi.org/10.1084/jem.20101597.CrossRefPubMedPubMedCentral

12.

Fuchs S, Rensing-Ehl A, Speckmann C, Bengsch B, Schmitt-Graeff A, Bondzio I, et al. Antiviral and regulatory T cell immunity in a patient with STIM1 deficiency. J Immunol (Baltimore, Md : 1950). 2012;188(3):1523–33. https://doi.org/10.4049/jimmunol.1102507.CrossRef

13.

Maus M, Jairaman A, Stathopulos PB, Muik M, Fahrner M, Weidinger C, et al. Missense mutation in immunodeficient patients shows the multifunctional roles of coiled-coil domain 3 (CC3) in STIM1 activation. Proc Natl Acad Sci U S A. 2015;112(19):6206–11.CrossRefPubMedPubMedCentral

14.

Canna SW, Goldbach-Mansky R. New monogenic autoinflammatory diseases--a clinical overview. Semin Immunopathol. 2015;37(4):387–94.CrossRefPubMedPubMedCentral

15.

Lian J, Cuk M, Kahlfuss S, Kozhaya L, Vaeth M, Rieux-Laucat F, et al. ORAI1 mutations abolishing store-operated Ca²⁺ entry cause anhidrotic ectodermal dysplasia with immunodeficiency. J Allergy Clin Immunol. 2018;142(4):1297–1310.e1.CrossRefPubMed

16.

Schaballie H, Rodriguez R, Martin E, Moens L, Frans G, Lenoir C, et al. A novel hypomorphic mutation in STIM1 results in a late-onset immunodeficiency. J Allergy Clin Immunol. 2015;136(3):816–819.e4. https://doi.org/10.1016/j.jaci.2015.03.009.CrossRefPubMed

17.

Wang S, Choi M, Richardson AS, Reid BM, Seymen F, Yildirim M, et al. STIM1 and SLC24A4 are critical for enamel maturation. J Dent Res. 2014;12:94S–100S.CrossRef

Titel: A Report of Novel STIM1 Deficiency and 6-Year Follow-Up of Two Previous Cases Associated with Mild Immunological Phenotype
verfasst von: Laura Rice
Claire Stockdale
Ian Berry
Sean O’Riordan
Karen Pysden
Rashida Anwar
Roger Rushambuza
Moira Blyth
Sonal Srikanth
Yousang Gwack
Yasser M. El-Sherbiny
Clive Carter
Sinisa Savic
Publikationsdatum: 04.04.2019
Verlag: Springer US
Erschienen in: Journal of Clinical Immunology / Ausgabe 3/2019
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-019-00618-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

A Report of Novel STIM1 Deficiency and 6-Year Follow-Up of Two Previous Cases Associated with Mild Immunological Phenotype

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Successful Treatment of Sinusitis with Topical Human Milk in a Lymphoma Patient Using Rituximab

Successful Rituximab Treatment for Lymphoma, Secondary Immunodeficiency Causing Debilitating Sinusitis: Underlying Primary Immunodeficiency Disease, and Alternative Treatments to Improve the Quality of Life?

Hemorrhagic Pneumonia as the First Manifestation of Anhidrotic Ectodermal Dysplasia with Immunodeficiency

Fatal Enteroviral Encephalitis in a Patient with Common Variable Immunodeficiency Harbouring a Novel Mutation in NFKB2

Revisiting Fatal Granulomatous Disease of Childhood Through an Autopsy: Still Lethal in the Developing World!

Interleukin-36 Receptor Antagonist Deficiency (DITRA) with a Novel IL36RN Homozygous Mutation c.200G > T (P.Cys67Phe) in a Young Colombian Woman

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin